No Data
No Data
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1333> Maruha Nichiro 3083 2918 <1887> Japan Land Development 520 496 <1950> Nippon Densetsu 2152 2046 <2264 > Morinaga Milk 3105 2945 <2270> Snow Brand Meg 2
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1720> Tokyu Construction 839 829.75 820.5 <1979> Taikisha 4685 4652.5 4467.5 <2461> Fan Review 402 401 400 <2733> New
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1976> Meisei Kogyo 1231 1230.5 1178.5 <5970> G-TEKT 2073 2014.25 1886.5 <6740> JDI 22 21.75 20 <7453> Good Product Plan 2338
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <2922> Natori 2114 2179 <2931> Euglena 605 641 <3002> Gunze 5420 5680 <3036> Alconix 1435 1496 <3087> Doutor Day Less
Transfer of the rights of “Melislon” and “Mionar” in Japan to Kinkaku Pharmaceutical
For printing 2024/3/29, Eisai Co., Ltd. (Headquarters: Tokyo; Representative Executive Officer and CEO: Haruo Naito) is pleased to announce that it has now signed an agreement to transfer domestic rights to the vertigo and balance disorder treatment agent “Melisone” (generic name: betahistine mesylate) and the muscle tone improving agent “Mional” (generic name: eperisone hydrochloride) to Kagaku Pharmaceutical Co., Ltd. (Headquarters: Tokyo, hereinafter referred to as Kaken Pharmaceutical). “Merislon” and “Mionard” are those in Japan
Care net, Tohokushinsha, etc. [5% rule]
<2121>MIXI Co., Ltd. Kenji Kasahara Stock Ownership Ratio 42.19% → 44.11% Reporting Obligation Date 2024/03/19 <2150>Care Net Co., Ltd. Medical Incubator Japan Stock Holding Ratio 17.57% → 17.01% Reporting Obligation Date 2024/03/21 <2329>Tohoku Shinsha Co., Ltd. 3D Investment Partners Private Limited (3D Inns)
No Data